Selected Investments

Backed by PMEP
PM Equity Partner offers various type of collaboration agreements and investment formats. To date PM Equity Partner has invested in sixteen companies with selected examples below:

Neuro

Logo path
/content/dam/pmequitypartner/20240820 Neuro_active_transparent_grey2.png
Color logo path
/content/dam/pmequitypartner/20240820 Neuro_active_transparent.png
Internal url
/content/pmequitypartner/en/backed-by-pmep#neuro
Title
Energy In Your Pocket
Website url
https://neurogum.com/
Image Composition
/content/dam/pmequitypartner/portfolio-products/images/neuro.png
Description

Supplement product gums and mints to energize, calm and focus by providing key nutrients for improved performance up to 5 times more quickly than drinks or capsules and without the effects of caffeine. Anytime, anywhere.

Background Image
/content/dam/pmequitypartner/backgrounds/bg-image6.png

Moodify

Logo path
/content/dam/pmequitypartner/20240820 Moodify_active_transparent_grey3.png
Color logo path
/content/dam/pmequitypartner/20240820 Moodify_active_transparent.png
Internal url
/content/pmequitypartner/en/backed-by-pmep#moodify
Title
Advanced Active Scents For Enhanced Well Being​
Website url
https://www.moodify.ai/
Image Composition
/content/dam/pmequitypartner/portfolio-products/images/moodify.png
Description

Moodify Scent Technologies enable brands and fragrance houses to create and control scent experiences for their products. Scents developed with Moodify have radically reduced time and cost to market, enabling scalable, sustainable, and compliant production.

Moodify’s multi-patented Scent AI™ technologies combine deep scent industry expertise with advanced machine learning, physics, chemistry and neuroscience to crack the code of dynamic scent development and delivery.

Moodify solutions include Malodor Control for packaged goods, places and pets, and Reformulations for personal care and home care. Moodify also partners with product innovators from entertainment and retail to consumer electronics, creating new dynamic scent experiences that their customers will love.

Moodify is based on tight collaboration with the Weizman Olfactory Research Group, combining over a decade of academic research with cutting-edge industry knowledge in computer science, material science, and fragrance design.

Background Image
/content/dam/pmequitypartner/backgrounds/bg-image5.png

Comet

Logo path
/content/dam/pmequitypartner/20240820 Comet_exited_transparent_grey2.png
Color logo path
/content/dam/pmequitypartner/20240820 Comet_exited_transparent.png
Internal url
/content/pmequitypartner/en/backed-by-pmep#comet
Title
Transforming Bio-waste Into Sustainable Food Ingredients
Website url
https://comet-bio.com/
Image Composition
/content/dam/pmequitypartner/portfolio-products/images/comet.png
Description

Comet Bio is an award-winning food technology company based in London, Ontario, and Schaumburg, Illinois. The company makes unique, healthy, and sustainable products using its patented upcycling technology. Its Arrabina Arabinoxylan Plant Fiber Extract is a premium prebiotic dietary fiber with superior tolerability and functionality. The company's line of Sweeterra syrups is a sustainable and lower sugar alternative to traditional sweeteners with no trade-offs in terms of taste and performance.

Background Image
/content/dam/pmequitypartner/backgrounds/bg-image.png

Biognosys

Logo path
/content/dam/pmequitypartner/20240820 Biognosys_exited_transparent_grey3.png
Color logo path
/content/dam/pmequitypartner/20240820 Biognosys_exited_transparent.png
Internal url
/content/pmequitypartner/en/backed-by-pmep#biognosys
Title
Leading Global Proteomics Company That Offers Large-scale Proteomics Solutions Based On Proprietary Mass Spectrometry Technology
Website url
https://biognosys.com/
Image Composition
/content/dam/pmequitypartner/portfolio-products/images/biognosys.png
Description

Biognosys is the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development. The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision-making.

PM Equity Partner has exited its investment in Biognosys.

Background Image
/content/dam/pmequitypartner/backgrounds/bg-image3.png

Treatech

Logo path
/content/dam/pmequitypartner/20240820 Treatech_exited_transparent_grey2.png
Color logo path
/content/dam/pmequitypartner/20240820 Treatech_exited_transparent.png
Internal url
/content/pmequitypartner/en/backed-by-pmep#treatech
Title
Reinventing Liquid Waste Treatment
Website url
https://trea-tech.com/
Image Composition
/content/dam/pmequitypartner/portfolio-products/images/treatech.png
Description

Treatech is disrupting the waste water treatment industry by bringing to market an innovative technology that captures the full value of a broad range of end products including renewable gas, clean water, salt, and minerals.

In 2023, PM Equity Partner has successfully exited its investment in Treatech as part of a Series A funding led by strategic investors.

Background Image
/content/dam/pmequitypartner/backgrounds/bg-image4.png

Azuri

Logo path
/content/dam/pmequitypartner/20240820 Azuri_active_transparent_grey3.png
Color logo path
/content/dam/pmequitypartner/20240820 Azuri_active_transparent.png
Internal url
/content/pmequitypartner/en/backed-by-pmep#azuri
Title
Providing Solar Energy And Consumer Electronics To Rural Communities
Website url
https://www.azuri-group.com/
Image Composition
/content/dam/pmequitypartner/portfolio-products/images/azuri.png
Description

Azuri has delivered affordable solar home systems on a commercial basis to customers in 12 countries in sub-Saharan Africa. The company has sold more than 150,000 systems, impacting more than 750,000 lives.

Azuri's long-term vision is to bridge the digital and services gap that exists between urban and rural communities through the power of solar.

Background Image
/content/dam/pmequitypartner/backgrounds/bg-image6.png

Softhale

Logo path
/content/dam/pmequitypartner/20240820 Softhale_exited_transparent_grey5.png
Color logo path
/content/dam/pmequitypartner/20240820 Softhale_exited_transparent.png
Internal url
/content/pmequitypartner/en/backed-by-pmep#softhale
Title
Novel Inhalation Technology
Website url
https://www.softhale.com/
Image Composition
/content/dam/pmequitypartner/portfolio-products/images/softhale.png
Description

Softhale is developing pharmaceutical inhalation products for major respiratory markets in the U.S., Europe, and Asia. These products are based upon a differentiated inhalation delivery technology called SOFTHALER®. This device is a next-generation Soft Mist Inhaler (SMI), which offers a platform technology for delivering various drugs to the lungs. As well as generic products, innovative products are also targeted.

PM Equity Partner has exited its investment in Softhale.

Background Image
/content/dam/pmequitypartner/backgrounds/bg-image5.png